India reports first suspected mpox case; patient's condition stable

Samples from the patient, put under isolation, currently being tested to confirm presence of the virus

Monkeypox
(Photo: Shutterstock)
Sanket Koul New Delhi
2 min read Last Updated : Sep 08 2024 | 5:17 PM IST
India on Sunday reported the first suspected case of mpox virus in a young male patient, who had recently travelled from a country witnessing an outbreak of the disease.

In a statement, the Union Health Ministry did not clarify which city the case was found in.

“A young male patient, who recently travelled from a country currently experiencing mpox transmission, has been identified as a suspect case of mpox,” a communication from the ministry stated.

The patient has been put under isolation in a designated hospital, and is currently stable. Samples from the patient are currently being tested to confirm the presence of mpox. 

“The case is being managed in line with established protocols, and contact tracing is ongoing to identify potential sources and assess the impact within the country,” the ministry added.

Highlighting that there was no cause for concern, the ministry added that the country is fully prepared to deal with such isolated travel-related cases and has robust measures in place to manage and mitigate any potential risk.

India’s health apparatus has been on alert ever since the World Health Organisation (WHO) classified mpox as a public health emergency of international concern (PHEIC) after a surge in cases in African countries last month.

Cases were also found in countries such as Sweden and Pakistan, swinging state and central health authorities in India into action. 

Mpox, or monkeypox is a zoonotic disease, which can be transmitted through direct contact with infectious skin or other lesions (mouth, genitals). Infection can also occur via use of contaminated objects such as clothing or linens or in a community setting.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :MonkeypoxMpoxHealth MinistryWorld Health Organisation

First Published: Sep 08 2024 | 5:02 PM IST

Next Story